Efficacy of Extended-Interval Dosing of Micafungin Evaluated Using a Pharmacokinetic/Pharmacodynamic Study with Humanized Doses in Mice.

about

We can do better: a fresh look at echinocandin dosing.

P2860

Q50118613-A7DE4DD5-309C-4005-A997-8C0052CEFBB7

P2860

Efficacy of Extended-Interval Dosing of Micafungin Evaluated Using a Pharmacokinetic/Pharmacodynamic Study with Humanized Doses in Mice.

Item

http://www.wikidata.org/entity/Q40916536

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Efficacy of Extended-Interval ...... with Humanized Doses in Mice.

@en

type

Item

label

Efficacy of Extended-Interval ...... with Humanized Doses in Mice.

@en

prefLabel

Efficacy of Extended-Interval ...... with Humanized Doses in Mice.

@en

P1476

Efficacy of Extended-Interval ...... y with Humanized Doses in Mice

@en

P2093

A Lepak

http://www.w3.org/2001/XMLSchema#string

J VanHecker

http://www.w3.org/2001/XMLSchema#string

K Marchillo

http://www.w3.org/2001/XMLSchema#string

N Azie

http://www.w3.org/2001/XMLSchema#string

P2860

Pharmacokinetic and maximum tolerated dose study of micafungin in combination with fluconazole versus fluconazole alone for prophylaxis of fungal infections in adult patients undergoing a bone marrow or peripheral stem cell transplant.

Accumulated safety data of micafungin in therapy and prophylaxis in fungal diseases.

Safety, tolerability, and pharmacokinetics of Micafungin (FK463) in febrile neutropenic pediatric patients.

Characterization and quantitation of the pharmacodynamics of fluconazole in a neutropenic murine disseminated candidiasis infection model.

In vivo characterization of the pharmacodynamics of flucytosine in a neutropenic murine disseminated candidiasis model.

Postantifungal effects of echinocandin, azole, and polyene antifungal agents against Candida albicans and Cryptococcus neoformans

Pharmacodynamics of amphotericin B in a neutropenic-mouse disseminated-candidiasis model

Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis.

Pharmacodynamics of caspofungin in a murine model of systemic candidiasis: importance of persistence of caspofungin in tissues to understanding drug activity.

Micafungin versus fluconazole for prophylaxis against invasive fungal infections during neutropenia in patients undergoing hematopoietic stem cell transplantation.

P304

674-677

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.02124-15

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

David Andes

P577

2015-11-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26552968

http://www.w3.org/2001/XMLSchema#string

P932

4704180

http://www.w3.org/2001/XMLSchema#string

Efficacy of Extended-Interval Dosing of Micafungin Evaluated Using a Pharmacokinetic/Pharmacodynamic Study with Humanized Doses in Mice.

about

P2860

P2860

Efficacy of Extended-Interval Dosing of Micafungin Evaluated Using a Pharmacokinetic/Pharmacodynamic Study with Humanized Doses in Mice.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932